Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
methylprednisolone (medrol) (1 trial)
nilotinib (tasigna) (1 trial)
sodium chloride (1 trial)
Acute Lung Injury (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphoid (Phase 2)
Lung Injury (Phase 2)
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)
Respiratory Distress Syndrome (Phase 2)
Respiratory Distress Syndrome, Newborn (Phase 2)
Trials (2 total)
Trial APIs (3 total)